[News Article]Dr. Jin-San Yoo, CEO of PharmAbcine is joining for the ``Critical Issues in Tumor Microenvironment: Angiogenesis, Metastasis and Immunology``...

14 Jan 2019
Title
Dr. Jin-San Yoo, CEO of PharmAbcine is joining for the ``Critical Issues in Tumor Microenvironment: Angiogenesis, Metastasis and Immunology`` of Tumor Course of Harvard Medical School and for networking on September 5-8th, 2017.
Category
News Article


Dr. Jin-San Yoo, CEO of PharmAbcine is joining for the "Critical Issues in Tumor Microenvironment: Angiogenesis, Metastasis and Immunology" of Tumor Course of Harvard Medical School and for networking on September 5-8th, 2017.




     2F, Research Building 2, 70,

     Yuseong-daero 1689 beon-gil,
     Yuseong-gu, Daejeon, 34047, Republic of Korea


     HQ +82-42-863-2017 

     R&D Center +82-42-861-2017

     Investor Relations +70-4294-6097 

     FAX +82-42-863-2080 


     COPYRIGHT BY PharmAbcine Inc.

     ALL RIGHTS RESERVE